FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first…
Read More
Recently, David Blue and Matt Ahearn presented on the latest with Shoulder Innovations at the 2022 LSI Emerging Medtech Summit. Watch the replay here: Play Video
Read More
We’re excited to announce the addition of Len Tokish to the Genesis team as the new Vice President of Quality.
Medical Ingenuities Conducts First Commercial Cases with Transformational Radial Hemostasis Band System to Achieve Patent Hemostasis On February 21st, board-certified cardiologist, Dr. Vivek V. Kumar, completed 4 radial cases at...
Read More
GRAND RAPIDS, Mich., March 14, 2022—Shoulder Innovations Inc., (SI), a leading innovator in the development of shoulder replacement systems, announces the FDA Clearance of their latest component of the InSetTM Total Shoulder System, the…
Grand Rapids, Mich., January 24, 2022– Magnesium Development Company (MDC), a company with an innovative magnesium (Mg) alloy technology set out to solve what seemed to be an unsolvable problem: the…
Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced its…
Grand Rapids, MI. – December 1st, 2021 – Genesis Innovation Group’s cultivate(MD) Capital Funds announces that one of their portfolio companies, Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots…
Virtual Incision Announces $46 Million Financing to Advance First-of-its-Kind MIRA Surgical Platform
Lincoln, Neb., and Pleasanton, Calif. – November 30, 2021 – Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, today announced it has raised $46…
HAPPE Spine announces that it has closed on a $3.35 million Series A capital raise.
